Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Search
Search results
Webinar: Mark Goes to Las Vegas
Listen to our webinar to hear about our Information and Support Coordinator, Mark Baxter's, holiday in Las Vegas.
Webinar: Together We Can: ways you can get involved!
Together We Can: ways you can get involved!
Webinar: Miles for Vision: Behind the Scenes of the London Marathon 2025
The latest webinar from Retina UK.
Johnson & Johnson gene therapy update – What happens now?
The latest research news from Retina UK.
Tribute to Retina UK founder Lynda Cantor MBE
Tribute to Retina UK founder Lynda Cantor MBE
Look Forward – Autumn 2025 – Issue 187
Since the publication of this newsletter our founder and honorary president Lynda Cantor MBE has passed away. We are all deeply saddened by this news.
Cell-ebrating the dosing of patients with jCell in a phase 2 clinical trial for RP
The latest research news from Retina UK.
Our manifesto
Retina UK are committed to improving the lives of people affected by inherited retinal dystrophies (IRDs).
Meet a Researcher: Dr Jenny Dewing
Jenny Dewing is a postdoctoral researcher working on a Retina UK-funded project with Dr Arjuna Ratnayaka at the University of Southampton.